MValve Technologies Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
13
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$200M
MValve Technologies General Information
Description
Developer of percutaneous mitral valve replacement system designed to treat mitral regurgitation. The company's percutaneous mitral valve replacement system uses Lotus valve system technology for treating people with aortic stenosis, enabling patients to begin treatment more quickly.
Contact Information
Website
www.mvalvemed.comCorporate Office
- Medinat HaYehudim Street 91
- Herzliyya
- Tel Aviv
- Israel
Corporate Office
- Medinat HaYehudim Street 91
- Herzliyya
- Tel Aviv
- Israel
MValve Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 08-Oct-2015 | $200M | Completed | Startup | ||
| 3. Early Stage VC | 06-Jul-2014 | Completed | Startup | |||
| 2. Early Stage VC | 01-Jan-2012 | Completed | Startup | |||
| 1. Early Stage VC | Completed | Startup |
MValve Technologies Patents
MValve Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018025260-A1 | Intracardiac devices comprising wire-supported valve leaflets | Inactive | 31-Jul-2016 | ||
| EP-3432833-A1 | Replacement cardiac valve | Inactive | 22-Mar-2016 | ||
| US-20190099267-A1 | Replacement cardiac valve | Inactive | 22-Mar-2016 | ||
| WO-2017163247-A1 | Replacement cardiac valve | Inactive | 22-Mar-2016 | ||
| EP-3182933-A1 | Cardiac valve support devices having improved compatibility with transcatheter prosthetic valves | Inactive | 21-Aug-2014 | A61F2/2418 |
MValve Technologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
MValve Technologies Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boston Scientific Ventures | Corporate Venture Capital | Minority | ||
| XT Group | Holding Company | Minority |
MValve Technologies FAQs
-
When was MValve Technologies founded?
MValve Technologies was founded in 2012.
-
Where is MValve Technologies headquartered?
MValve Technologies is headquartered in Tel Aviv, Israel.
-
What is the size of MValve Technologies?
MValve Technologies has 13 total employees.
-
What industry is MValve Technologies in?
MValve Technologies’s primary industry is Surgical Devices.
-
Is MValve Technologies a private or public company?
MValve Technologies is a Private company.
-
What is the current valuation of MValve Technologies?
The current valuation of MValve Technologies is .
-
What is MValve Technologies’s current revenue?
The current revenue for MValve Technologies is .
-
How much funding has MValve Technologies raised over time?
MValve Technologies has raised $15M.
-
Who are MValve Technologies’s investors?
Boston Scientific Ventures and XT Group have invested in MValve Technologies.
-
When was MValve Technologies acquired?
MValve Technologies was acquired on 08-Oct-2015.
-
Who acquired MValve Technologies?
MValve Technologies was acquired by Boston Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
